Sign up to save your podcasts
Or
Share RET Inhibitors for RET-Altered Non-Small Cell Lung Cancer: Identification, Treatment, and Practicalities
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
RET Inhibitors for RET-Altered Non-Small Cell Lung Cancer: Identification, Treatment, and Practicalities
Did you know that RET fusions have been detected in 1% to 2% of all lung cancers and can be treated with available targeted therapies?
Credit available for this activity expires: 10/21/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982531?src=mkm_podcast_addon_982531
View all episodes
By Medscape Podcasts
4
77 ratings
Did you know that RET fusions have been detected in 1% to 2% of all lung cancers and can be treated with available targeted therapies?
Credit available for this activity expires: 10/21/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982531?src=mkm_podcast_addon_982531
More shows like Keeping Current
View all
Merriam-Webster's Word of the Day
1,257 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
299 Listeners
Science Quickly
1,388 Listeners
HBR IdeaCast
171 Listeners
This Week in Cardiology
883 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
The Peter Attia Drive
8,554 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
60 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners